Status:
RECRUITING
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
Helse Stavanger HF
Conditions:
Depressive Disorder
Eligibility:
All Genders
18+ years
Brief Summary
The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to s...
Detailed Description
Patients reffered to electroconvulsive ECT are (after written consent) enroled in a research registry. Based on (clinician and patient rated) measures of depressive symptoms and overall cognitive func...
Eligibility Criteria
Inclusion
- Patients treated with ECT for major depression (F31.3-5, F32, F33) at Haukeland University Hospital or Stavanger University Hospital after 2013,
- written consent to enrolment into the Regional Register for neurostimulation.
Exclusion
- ECT performed on other indications than major depression.
- No consent to the register.
Key Trial Info
Start Date :
March 13 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05388461
Start Date
March 13 2013
End Date
December 1 2028
Last Update
September 26 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5021
2
Stavanger University Hospital
Stavanger, Norway